abstract |
The present invention relates to 1-azabicycloalkyl derivatives of the formula (I), wherein the substituents are as defined in the specification, to procedures for their production, their use as pharmaceuticals in the prevention and treatment of psychotic disorders and neurodegenerative. The claimed compounds act as ligands for nicotinic acetylcholine receptors (NACHR). |